Successful Treatment of Staphylococcal Toxic Shock Syndrome with Linezolid: A Case Report and In Vitro Evaluation of the Production of Toxic Shock Syndrome Toxin Type 1 in the Presence of Antibiotics | Zendy

Dennis L. Stevens | Zendy; Randi J. Wallace | Zendy; S. M. Hamilton | Zendy; Amy E. Bryant | Zendy

Open Access

Successful Treatment of Staphylococcal Toxic Shock Syndrome with Linezolid: A Case Report and In Vitro Evaluation of the Production of Toxic Shock Syndrome Toxin Type 1 in the Presence of Antibiotics

Author(s) -

Dennis L. Stevens,

Randi J. Wallace,

S. M. Hamilton,

Amy E. Bryant

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/500265

Subject(s) - linezolid , medicine , antibiotics , toxic shock syndrome , shock (circulatory) , toxin , in vitro , microbiology and biotechnology , staphylococcus aureus , bacteria , vancomycin , biology , biochemistry , genetics

Figure 1. Antibiotic effects on the growth of Staphylococcus aureus and the production of toxic shock syndrome toxin (TSST)–1. The patient’s strain of S. aureus was cultured in the absence or presence of antibiotics at the indicated final concentrations. Antibiotics were added 4 h after initiation of cultures. Bacterial growth (A) and TSST-1 production (B) were measured by plate counts and ELISA assay, respectively. Data are from 1 representative experiment of 3 and represent the mean of duplicate measurements SD. CFU, colony-forming units. www2.infinit.com/cgi-bin/imprimer.cgi?idp1 48834. Accessed 24 January 2006.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research